BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Madhi F, Levy C, Morin L, Minodier P, Dubos F, Zenkhri F, Dommergues MA, Mezgueldi E, Levieux K, Béchet S, Varon E, Cohen R; Pneumonia Study Group ., GPIP (Pediatric Infectious Disease Group) . Change in Bacterial Causes of Community-Acquired Parapneumonic Effusion and Pleural Empyema in Children 6 Years After 13-Valent Pneumococcal Conjugate Vaccine Implementation. J Pediatric Infect Dis Soc 2019;8:474-7. [PMID: 30407519 DOI: 10.1093/jpids/piy103] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Molloy MJ, Thomson JE. A complicated decision: Empiric antibiotics in children with complicated pneumonia. Journal of Hospital Medicine. [DOI: 10.1002/jhm.2738] [Reference Citation Analysis]
2 Hoshino T, Nishima D, Enseki M, Umehara N, Fukasawa C, Ishiwada N. Pediatric Parapneumonic Effusion/Pleural Empyema in Japan: A Nationwide Survey. Pediatr Infect Dis J 2022;41:20-3. [PMID: 34862346 DOI: 10.1097/INF.0000000000003353] [Reference Citation Analysis]
3 Andrés-Martín A, Escribano Montaner A, Figuerola Mulet J, García García ML, Korta Murua J, Moreno-Pérez D, Rodrigo-Gonzalo de Liria C, Moreno Galdó A. Consensus Document on Community-Acquired Pneumonia in Children. SENP-SEPAR-SEIP. Arch Bronconeumol (Engl Ed) 2020;56:725-41. [PMID: 32534869 DOI: 10.1016/j.arbres.2020.03.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Markham JL, Hackman S, Hall M, Burns A, Goldman JL. Inpatient outcomes for children receiving empiric methicillin‐resistant Staphylococcus aureus coverage for complicated pneumonia. Journal of Hospital Medicine. [DOI: 10.1002/jhm.2736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. The Lancet 2020;396:786-98. [DOI: 10.1016/s0140-6736(20)31550-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 10.5] [Reference Citation Analysis]
6 Dudognon D, Levy C, Chalumeau M, Biscardi S, Dommergues MA, Dubos F, Levieux K, Aurel M, Minodier P, Zenkhri F, Mezgueldi E, Craiu I, Morin L, Béchet S, Varon E, Cohen R, Cohen JF; Pneumonia Study Group. Diagnostic Accuracy of Routinely Available Biomarkers to Predict Bacteremia in Children With Community-Acquired Pneumonia: A Secondary Analysis of the GPIP/ACTIV Pneumonia Study in France, 2009-2018. Front Pediatr 2021;9:684628. [PMID: 34746044 DOI: 10.3389/fped.2021.684628] [Reference Citation Analysis]
7 Strachan R, Homaira N, Beggs S, Bhuiyan MU, Gilbert GL, Lambert SB, Macartney K, Marshall H, Martin AC, McCallum GB, McCullagh A, McDonald T, McIntyre P, Oftadeh S, Ranganathan S, Suresh S, Wainwright CE, Wilson A, Wong M, Snelling T, Jaffé A. Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia. Thorax 2021;76:487-93. [PMID: 33504566 DOI: 10.1136/thoraxjnl-2020-216032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sim JY, Chang LY, Chang TH, Chen JM, Lee PI, Huang LM, Lu CY. Pediatric parapneumonic effusion before and after national pneumococcal vaccination programs in Taiwan. J Formos Med Assoc 2020;119:1608-18. [PMID: 32747171 DOI: 10.1016/j.jfma.2020.07.026] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Meyer Sauteur PM, Burkhard A, Moehrlen U, Relly C, Kellenberger C, Ruoss K, Berger C. Pleural Tap-Guided Antimicrobial Treatment for Pneumonia with Parapneumonic Effusion or Pleural Empyema in Children: A Single-Center Cohort Study. J Clin Med 2019;8:E698. [PMID: 31100958 DOI: 10.3390/jcm8050698] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
10 Del Rosal T, Caminoa MB, González-Guerrero A, Falces-Romero I, Romero-Gómez MP, Baquero-Artigao F, Sainz T, Méndez-Echevarría A, Escosa-García L, Aracil FJ, Calvo C. Outcome of Severe Bacterial Pneumonia in the Era of Pneumococcal Vaccination. Front Pediatr 2020;8:576519. [PMID: 33384973 DOI: 10.3389/fped.2020.576519] [Reference Citation Analysis]
11 Leoni MC, Hau I, Biscardi S, Jung C, Delestrain C, Mangiapan G, Nattes E, Madhi F, Epaud R. [Antibiotic strategy in pleural empyema in children: Consensus by the DELPHI method]. Rev Mal Respir 2020;37:443-50. [PMID: 32439250 DOI: 10.1016/j.rmr.2020.04.010] [Reference Citation Analysis]
12 Esposito S, Dal Canto G, Caramia MR, Fainardi V, Pisi G, Principi N. Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age. Expert Rev Anti Infect Ther 2021;:1-7. [PMID: 33971782 DOI: 10.1080/14787210.2021.1927710] [Reference Citation Analysis]
13 Carloni I, Ricci S, Rubino C, Cobellis G, Rinaldelli G, Azzari C, de Benedictis FM. Necrotizing pneumonia among Italian children in the pneumococcal conjugate vaccine era. Pediatr Pulmonol 2021;56:1127-35. [PMID: 33442941 DOI: 10.1002/ppul.25270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Lodi L, Ricci S, Nieddu F, Moriondo M, Lippi F, Canessa C, Mangone G, Cortimiglia M, Casini A, Lucenteforte E, Indolfi G, Resti M, Azzari C. Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children. Vaccines (Basel) 2019;7:E128. [PMID: 31554213 DOI: 10.3390/vaccines7040128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
15 Torres A, Menéndez R, España PP, Fernández-Villar JA, Marimón JM, Cilloniz C, Méndez R, Egurrola M, Botana-Rial M, Ercibengoa M, Méndez C, Cifuentes I, Gessner BD; CAPA Study Group. The Evolution and Distribution of Pneumococcal Serotypes in Adults Hospitalized With Community-Acquired Pneumonia in Spain Using a Serotype-Specific Urinary Antigen Detection Test: The CAPA Study, 2011-2018. Clin Infect Dis 2021;73:1075-85. [PMID: 33851220 DOI: 10.1093/cid/ciab307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Le Saux NMA, Bowes J, Viel-Thériault I, Thampi N, Blackburn J, Buba M, Harrison MA, Barrowman N. Combined influence of practice guidelines and prospective audit and feedback stewardship on antimicrobial treatment of community-acquired pneumonia and empyema in children: 2012 to 2016. Paediatr Child Health 2021;26:234-41. [PMID: 34136053 DOI: 10.1093/pch/pxaa066] [Reference Citation Analysis]